JP2023538563A5 - - Google Patents
Info
- Publication number
- JP2023538563A5 JP2023538563A5 JP2023511894A JP2023511894A JP2023538563A5 JP 2023538563 A5 JP2023538563 A5 JP 2023538563A5 JP 2023511894 A JP2023511894 A JP 2023511894A JP 2023511894 A JP2023511894 A JP 2023511894A JP 2023538563 A5 JP2023538563 A5 JP 2023538563A5
- Authority
- JP
- Japan
- Prior art keywords
- binder
- fusion protein
- rnase
- toxin fusion
- toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20191419 | 2020-08-17 | ||
| EP20191417 | 2020-08-17 | ||
| EP20191419.9 | 2020-08-17 | ||
| EP20191417.3 | 2020-08-17 | ||
| EP21156276.4 | 2021-02-10 | ||
| EP21156276 | 2021-02-10 | ||
| EP21156837.3 | 2021-02-12 | ||
| EP21156837 | 2021-02-12 | ||
| EP21186435 | 2021-07-19 | ||
| EP21186435.0 | 2021-07-19 | ||
| PCT/EP2021/072859 WO2022038152A1 (en) | 2020-08-17 | 2021-08-17 | Recombinant immunotoxin comprising a ribotoxin or rnase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538563A JP2023538563A (ja) | 2023-09-08 |
| JP2023538563A5 true JP2023538563A5 (enExample) | 2024-08-26 |
| JP7818834B2 JP7818834B2 (ja) | 2026-02-24 |
Family
ID=80350379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023511894A Active JP7818834B2 (ja) | 2020-08-17 | 2021-08-17 | リボトキシンまたはＲＮＡｓｅを含む組換え免疫毒素 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230310557A1 (enExample) |
| EP (1) | EP4196593A1 (enExample) |
| JP (1) | JP7818834B2 (enExample) |
| KR (1) | KR20230048435A (enExample) |
| CN (1) | CN116390947A (enExample) |
| CA (1) | CA3187245A1 (enExample) |
| IL (1) | IL300701A (enExample) |
| WO (1) | WO2022038152A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4568997A1 (en) * | 2022-08-08 | 2025-06-18 | ATB Therapeutics | Humanized antibodies against cd79b |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US6140075A (en) | 1994-07-25 | 2000-10-31 | Monsanto Company | Method for producing antibodies and protein toxins in plant cells |
| ES2176484T3 (es) | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
| US7053202B2 (en) | 2001-10-19 | 2006-05-30 | Millennium Pharmaceuticals, Inc. | Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor |
| WO2003068821A2 (en) * | 2002-02-14 | 2003-08-21 | Immunomedics, Inc. | Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| WO2003073843A2 (en) | 2002-03-05 | 2003-09-12 | Artemis Pharmaceuticals Gmbh | Inbred embryonic stem-cell derived mice |
| US20120276100A1 (en) * | 2005-04-06 | 2012-11-01 | Ibc Pharmaceuticals, Inc. | Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity |
| TW200732350A (en) | 2005-10-21 | 2007-09-01 | Amgen Inc | Methods for generating monovalent IgG |
| PE20090943A1 (es) | 2007-07-16 | 2009-08-05 | Genentech Inc | Anticuerpos anti-cd79b e inmunoconjugados |
| KR101607346B1 (ko) * | 2008-01-31 | 2016-03-29 | 제넨테크, 인크. | 항-ｃｄ７９ｂ 항체 및 면역접합체 및 사용 방법 |
| US20130145502A1 (en) | 2010-06-09 | 2013-06-06 | Pioneer Hi-Bred International, Inc. | Regulatory sequences for modulating transgene expression in plants |
| PL397167A1 (pl) * | 2011-11-28 | 2013-06-10 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Przeciwnowotworowe bialko fuzyjne |
| PL2971038T3 (pl) * | 2013-03-14 | 2020-04-30 | Research Corporation Technologies, Inc. | Cząsteczki rybotoksyny pochodzące z sarcyny i inne powiązane grzybowe rybotoksyny |
| US20160304617A1 (en) * | 2013-06-17 | 2016-10-20 | Asana Biosciences, Llc | 5t4-targeted immunofusion molecule and methods |
| EP3155006B1 (en) * | 2014-06-13 | 2019-08-07 | University of Cape Town | Human cytolytic fusion proteins |
| CN107428840A (zh) * | 2015-03-25 | 2017-12-01 | 弗劳恩霍夫应用研究促进协会 | 抗cd89细胞毒素的复合物 |
| WO2017053290A1 (en) * | 2015-09-23 | 2017-03-30 | Research Corporation Technologies, Inc. | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins |
| CN115925972A (zh) | 2019-02-18 | 2023-04-07 | Atb治疗公司 | 在植物细胞或整株植物中产生结合物-毒素融合蛋白的方法 |
-
2021
- 2021-08-17 JP JP2023511894A patent/JP7818834B2/ja active Active
- 2021-08-17 IL IL300701A patent/IL300701A/en unknown
- 2021-08-17 CA CA3187245A patent/CA3187245A1/en active Pending
- 2021-08-17 WO PCT/EP2021/072859 patent/WO2022038152A1/en not_active Ceased
- 2021-08-17 EP EP21765873.1A patent/EP4196593A1/en active Pending
- 2021-08-17 US US18/041,770 patent/US20230310557A1/en active Pending
- 2021-08-17 CN CN202180070465.2A patent/CN116390947A/zh active Pending
- 2021-08-17 KR KR1020237009135A patent/KR20230048435A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MacEachran et al. | The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator | |
| RU2214420C2 (ru) | Гибридный белок для ингибирования дегрануляции мастоцитов и его применение | |
| Saveanu et al. | Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum | |
| DK2281005T3 (en) | Single domain antibodies able to modulate bace1 activity | |
| WO1998011237A1 (en) | Self-secreting proteases | |
| AU2006256891B2 (en) | Use of the ideS proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection | |
| CN108350039A (zh) | 用于治疗疼痛的组合物和方法 | |
| Jiang et al. | Structure− function analysis of the auxilin J-domain reveals an extended Hsc70 interaction interface | |
| Hsu et al. | Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis | |
| KR20190015240A (ko) | 보툴리눔 신경독소의 정제 및 활성화 방법 | |
| Jané-Valbuena et al. | Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein σ3 | |
| JP2003522117A (ja) | 治療薬の送達のための二機能性分子 | |
| US10640573B2 (en) | Human antibody against aggrecanase-type ADAMTS species for therapeutics of aggrecanase-related diseases | |
| Kooi et al. | Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease | |
| Onuoha et al. | Rational design of antirheumatic prodrugs specific for sites of inflammation | |
| JP2023538563A5 (enExample) | ||
| CN117860891A (zh) | 一种抗结核分枝杆菌酰基转移酶靶点Rv1505c及其应用 | |
| US6822076B2 (en) | Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof | |
| Lyu et al. | Preventing SARS-CoV-2 infection using anti-spike nanobody-IFN-β conjugated exosomes | |
| Zhang et al. | mRNA vaccine against fibroblast activation protein ameliorates murine models of inflammatory arthritis | |
| Linardou et al. | A recombinant cytotoxic chimera based on mammalian deoxyribonuclease‐I | |
| CN104936618A (zh) | 针对活化蛋白c的人源化单克隆抗体及其用途 | |
| CN110716035B (zh) | 基于棘球蚴微管蛋白为靶点的抗棘球蚴病高通量药物筛选方法 | |
| CA2096953A1 (en) | Immunoglobulin-binding proteins and recombinant dna molecules coding therefor | |
| Mondal et al. | A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle |